(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch: Osteoarthritis of the Knee or Hip If you have osteoarthritis of the knee or hip, you may qualify for this study. The research site is in Plano, Texas. More information Please see http://www.clinicalconnection.com/clinical_trials/condition/osteoarthritis.aspx. ----- Type 2 Diabetes This study of type 2 diabetes will evaluate the drug Albiglutide when used with other oral anti-diabetic medications. The research site is in Peoria, Ill. More information Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx. ----- Ocular Hypertension or Open Angle Glaucoma If you have ocular hypertension or open angle glaucoma and are using Xalatan to treat these conditions, you may qualify for this three-month study. The research site is in Santa Monica, Calif. More information Please see http://www.clinicalconnection.com/clinical_trials/condition/glaucoma.aspx. ----- Attention Deficit/Hyperactivity Disorder (ADHD - Adults) If you are an adult with ADHD who has been taking related medication for the past six months, you may qualify for this study. The research site is in Wildomar, Calif. More information Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=499. ----- Arthritis and Arthritic Pain If you are an adult with osteoarthritis of the knee or hip and are taking naproxen or celecoxib and receiving some relief, you may qualify for this study. The research site is in Rock Hill, S.C. More information Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=15. ----- Eczema (Atopic Dermatitis) If you are an adult with severe chronic hand eczema, you may qualify for this study. The research site is in Wheat Ridge, Colo. More information Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=211. ----- Copyright 2009 ClinicalConnection.com and CenterWatch. All rights reserved. Copyright © 2009 ScoutNews, LLC. All rights reserved. HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit Health News on healthfinder.gov. |
